Why Is GUARDIAN PHARMACY SV A (GRDN) Stock Up Today?

Why GRDN stock is up today

Guardian Pharmacy Services stock surged 15.56% to $45.53 in a single session driven by strong second-quarter results and upgraded financial guidance. The company raised its 2026 revenue and EBITDA outlook after reporting improved profitability and growth in residents served. The stock opened with a 9.3% gap up and reached an intraday high of $45.80 before settling at $45.53.

What Happened

Guardian Pharmacy Services (NYSE: GRDN) announced stronger-than-expected Q2 2026 financial results, including a non-GAAP EPS of $0.29, which beat estimates by $0.03. Revenue for the quarter reached $351.8 million, exceeding expectations by $11.35 million. The company also raised its FY2026 revenue guidance to a range of $1.43 billion to $1.45 billion from $1.4 billion to $1.42 billion. These updates reflect improved operational performance and a 13.5% year-to-date revenue increase. Additionally, Oppenheimer raised its price target for GRDN to $49 from $43, and Truist Securities increased its target to $47. The company also announced the appointment of CFO David Morris as COO and the acquisition of Wellness Concepts, though terms were not disclosed.

What The Data Shows

The stock opened at $43.15, a significant jump from the prior close of $39.47. It reached a session high of $45.80 at 9:40 AM ET before retreating slightly. The price trend shows a 52-week range of $19.30 to $44.00, with the current price near the upper end. The stock traded 0.0M shares so far, which is 0.1x the 3-month daily average. The market cap stands at $2.6 billion, with a P/E ratio of 47.2, reflecting strong investor optimism.

What To Watch

The company’s Q2 2026 earnings call transcript is available for further analysis, and investors may watch for additional guidance or strategic updates in the coming weeks. Coverage breadth and any further analyst revisions will also be key indicators of continued momentum.